BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ge Z, Sanders AJ, Ye L, Jiang WG. Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Exp Ther Med. 2011;2:167-172. [PMID: 22977485 DOI: 10.3892/etm.2011.206] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Diaz Arguello OA, Haisma HJ. Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy. Cancers (Basel) 2021;13:1543. [PMID: 33801589 DOI: 10.3390/cancers13071543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kulbay M, Bernier-Parker N, Bernier J. The role of the DFF40/CAD endonuclease in genomic stability. Apoptosis 2021;26:9-23. [PMID: 33387146 DOI: 10.1007/s10495-020-01649-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chang Z, Dang T, Che N, Yu H, Chai J, Chen W. Esophageal cancer cells convert the death signal from TRAIL into a stimulus for survival during acid/bile exposure. Dig Liver Dis 2020;52:1195-200. [PMID: 32505571 DOI: 10.1016/j.dld.2020.04.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Strizova Z, Snajdauf M, Stakheev D, Taborska P, Vachtenheim J Jr, Biskup J, Lischke R, Bartunkova J, Smrz D. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients. J Cancer Res Clin Oncol 2020;146:1979-92. [PMID: 32447483 DOI: 10.1007/s00432-020-03258-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bou-Dargham MJ, Liu Y, Sang QA, Zhang J. Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3. PLoS One 2018;13:e0207799. [PMID: 30513096 DOI: 10.1371/journal.pone.0207799] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
6 Zhao T, Xu Y, Ren S, Liang C, Zhou X, Wu J. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells. Exp Ther Med 2018;15:4370-8. [PMID: 29725377 DOI: 10.3892/etm.2018.5964] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Xu YC, Cui J, Zhang LJ, Zhang DX, Xing BC, Huang XW, Wu JX, Liang CJ, Li GM. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1. Chin Med J (Engl) 2018;131:82-7. [PMID: 29271385 DOI: 10.4103/0366-6999.221271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li J, Xie N, Yuan J, Liu L, Zhou Q, Ren X, Chen Q, Zhang G, Ruan Q, Chen YH, Wan X. DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis. Oncotarget 2017;8:107612-20. [PMID: 29296192 DOI: 10.18632/oncotarget.22544] [Reference Citation Analysis]
9 Childs BG, Gluscevic M, Baker DJ, Laberge RM, Marquess D, Dananberg J, van Deursen JM. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov 2017;16:718-35. [PMID: 28729727 DOI: 10.1038/nrd.2017.116] [Cited by in Crossref: 397] [Cited by in F6Publishing: 458] [Article Influence: 79.4] [Reference Citation Analysis]
10 Zhou XN, Li GM, Xu YC, Zhao TJ, Wu JX. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2. Chin Med J (Engl) 2016;129:2623-9. [PMID: 27779171 DOI: 10.4103/0366-6999.192775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 Liang DY, Hou YQ, Lou XL. Effect of silencing decoy receptor 3 on biological features of hepatoma cells. Shijie Huaren Xiaohua Zazhi 2017; 25(3): 234-240 [DOI: 10.11569/wcjd.v25.i3.234] [Reference Citation Analysis]
12 Han S, Liu L, Xu F, Chen S, Yuan W, Fu Z, Li D, Li D. A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China. Chin J Cancer Res 2016;28:435-43. [PMID: 27647972 DOI: 10.21147/j.issn.1000-9604.2016.04.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Zhang Y, Li D, Zhao X, Song S, Zhang L, Zhu D, Wang Z, Chen X, Zhou J. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells. Biochem Biophys Res Commun. 2015;463:1144-1151. [PMID: 26102031 DOI: 10.1016/j.bbrc.2015.06.074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
14 Lancrajan I, Schneider-Stock R, Naschberger E, Schellerer VS, Stürzl M, Enz R. Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS. J Cell Mol Med 2015;19:1656-71. [PMID: 25823874 DOI: 10.1111/jcmm.12540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
15 Wang M, Zhang N, Wang W, Wang B, Xu Z, Yang Y. Expression and function of vascular endothelial growth inhibitor in aged porcine bladder detrusor muscle cells. Biogerontology 2013;14:543-56. [PMID: 24030243 DOI: 10.1007/s10522-013-9460-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Aiba Y, Harada K, Komori A, Ito M, Shimoda S, Nakamura H, Nagaoka S, Abiru S, Migita K, Ishibashi H, Nakanuma Y, Nishida N, Kawashima M, Tokunaga K, Yatsuhashi H, Nakamura M. Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis. Liver Int 2014;34:679-88. [PMID: 24016146 DOI: 10.1111/liv.12296] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
17 Bedewy AM, Elgammal MM, Bedewy MM, El-Maghraby SM. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma. Ann Hematol. 2013;92:1359-1367. [PMID: 23652586 DOI: 10.1007/s00277-013-1775-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
18 Porquet N, Poirier A, Houle F, Pin AL, Gout S, Tremblay PL, Paquet ER, Klinck R, Auger FA, Huot J. Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3. BMC Cancer 2011;11:285. [PMID: 21722370 DOI: 10.1186/1471-2407-11-285] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]